Category: Cardiac Rhythm ManagementSyndicate content

Boston Scientific backs Iowa Approach's atrial fibrillation device

November 24, 2014 by Brad Perriello

Iowa Approach says it landed an investment from Boston Scientific for the ablation device it's developing to treat atrial fibrillation.

Boston Scientific backs Iowa Approach's atrial fibrillation device

Medtronic touts CRT data

November 17, 2014 by Brad Perriello

Meta-analyses of Medtronic-sponsored studies show the clinical and economic benefits of its cardiac resynchronization therapy devices.

Medtronic touts CRT data

Medtronic (NYSE:MDT) yesterday touted the results of meta-analyses of a group of company-sponsored studies of its cardiac resynchronization therapy devices, saying the data show the clinical and economic value its CRT portfolio.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic: Hemodialysis patients at risk for arrhythmia

November 14, 2014 by Val Kennedy

A Medtronic study shows hemodialysis patients experience significantly higher-than-expected rates of arrhythmia and that the episodes appeared to coincide with their treatment cycles.

Medtronic: Hemodialysis patients at risk for arrhythmia

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Boston Scientific logs reimbursement wins

November 14, 2014 by Brad Perriello

Boston Scientific reveals a trifecta of reimbursement wins for its S-ICD, including a new reimbursement code from the AMA, a 23% increase in the Medicare rate for implantation and an expansion of coverage by private insurer Aetna.

Boston Scientific logs reimbursement wins

Boston Scientific (NYSE:BSX) yesterday revealed a trifecta of reimbursement wins for its S-ICD subcutaneous defibrillator from the American Medical Assn., Medicare and Aetna.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic wins nod in Japan for Evera MRI-safe ICD

November 10, 2014 by Brad Perriello

Medtronic says it won Japanese approval for its Evera MRI SureScan implantable cardiac defibrillator for full-body MRI exams.

Medtronic wins nod in Japan for Evera MRI-safe ICD

Medtronic (NYSE:MDT) said it won approval from Japan's Ministry of Health, Labor and Welfare for its Evera MRI SureScan implantable cardiac defibrillator for use in full-body MRI scans.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Biotronik settles kickbacks case for $5m

November 7, 2014 by Brad Perriello

Biotronik pays $5 million but admits no liability to settle allegations that it used kickbacks to induce doctors to use its cardiac rhythm management devices.

Biotronik settles kickbacks case for $5m

Federal prosecutors yesterday said Biotronik agreed to pony up $4.9 million, but admitted no wrongdoing, to settle allegations that it ran a kickbacks scheme to induce physicians to use its cardiac rhythm management devices.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FDA OKs new AtriCure afib trial

November 3, 2014 by Brad Perriello

The FDA grants an investigational device exemption for an AtriCure study of patients with non-paroxysmal atrial fibrillation.

FDA OKs new AtriCure afib trial

AtriCure (NSDQ:ATRC) said it won an investigational device exemption from the FDA for a 1st-of-its-kind clinical trial involving patients with non-paroxysmal atrial fibrillation.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp